In our study, we have found that MMP-2 genes were downregulated in diabetic cardiopathy I, proteoglycans in cancer, estrogen signaling, fluid shear stress and atherosclerosis, relaxing signaling, bladder cancer, and GnRH signaling pathways (Supplementary File S1). This evidence concerns the gene GNRH1 and cancer.